Chemical Compound

[(1S)-2,2-difluorocyclopropyl][(1R,5S)-3-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone

CAS Registry Number 1883299-62-4
[(1S)-2,2-difluorocyclopropyl][(1R,5S)-3-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone 结构式
Primary record

[(1S)-2,2-difluorocyclopropyl][(1R,5S)-3-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone

库存
5,662 克
纯度
99.0 %
CAS
1883299-62-4

化合物标识与属性

CAS
1883299-62-4
PubChem CID
118878093
SMILES
CN1C=C(C=N1)NC2=NC=CC(=N2)N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]5CC5(F)F
Canonical SMILES
Cn1cc(Nc2nccc(N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1

名称与同义词

  • Brepocitinib
  • Brepocitinib [USAN]
  • PF-06700841
  • Brepocitinib (USAN)
  • RefChem:121326
  • PF-06700841 free base
  • BREPOCITINIB [INN]
  • 1883299-62-4
  • BREPOCITINIB [WHO-DD]
  • 3X8387Q25N
  • CHEMBL4297477
  • SCHEMBL17512502
  • UNII-3X8387Q25N
  • US9663526, Example 7
  • GTPL10459
  • BUWBRTXGQRBBHG-MJBXVCDLSA-N
  • BDBM329924
  • DTXSID801091591
  • BCP29931
  • EBC-00709
  • MFCD31813694
  • PF-841
  • WHO 11169
  • PF06700841
  • ZINC526061580
  • DB15003
  • Brepocitinib, PF-06700841 free base
  • compound 23 [PMID: 30113844]
  • NCGC00510805-01
  • DA-56738
  • TYK2/JAK1 Inhibitor PF-06700841
  • J3.766.214C
  • PF 06700841
  • D11537
  • A1004073
  • [(1S)-2,2-difluorocyclopropyl]-[(1R,5S)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone
  • [(1S)-2,2-difluorocyclopropyl]-[(1S,5R)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone
  • Methanone, ((1S)-2,2-difluorocyclopropyl)(3-(2-((1-methyl-1H-pyrazol-4-yl)amino)-4-pyrimidinyl)-3,8-diazabicyclo(3.2.1)oct-8-yl)-
  • [(1S)-2,2-difluorocyclopropyl][(1R,5S)-3-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone
  • ((1S)-2,2-difluorocyclopropyl)-((1S,5R)-3-(2-((1-methylpyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo(3.2.1)octan-8-yl)methanone
  • ((S)-2,2-difluorocyclopropyl)(3-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone
  • (1S)-2,2-DIFLUOROCYCLOPROPYL)(3-(2-((1-METHYL-1H-PYRAZOL-4-YL)AMINO)PYRIMIDIN-4-YL)-3,8-DIAZABICYCLO(3.2.1)OCTAN-8-YL)METHANONE
  • (2,2-Difluorocyclopropyl)-[3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone
  • 4-((1R,5S)-8-((1S)-2,2-difluorocyclopropanecarbonyl)-3,8-diazabicyclo(3.2.1)octan-3-yl)-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine
  • 4-[(1R,5S)-8-[(1S)-2,2-difluorocyclopropanecarbonyl]-3,8-diazabicyclo[3.2.1]octan-3-yl]-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine
  • 4-[(1R,5S)-8-[(1S)-2,2-difluorocyclopropanecarbonyl]-3,8-diazabicyclo[3.2.1]octan-3-yl]-N-(1-methylpyrazol-4-yl)pyrimidin-2-amine
  • G4J
  • PF 06700841; PF06700841; PF-6700841; PF 6700841; PF6700841;PF-841;PF 841;PF841